Manning & Napier Advisors LLC acquired a new stake in Humana Inc. (NYSE:HUM - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 3,554 shares of the insurance provider's stock, valued at approximately $1,412,000.
Other institutional investors have also modified their holdings of the company. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in shares of Humana by 4.1% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 250,330 shares of the insurance provider's stock valued at $66,207,000 after purchasing an additional 9,960 shares during the period. Sustainable Insight Capital Management LLC increased its position in Humana by 23.7% during the fourth quarter. Sustainable Insight Capital Management LLC now owns 24,757 shares of the insurance provider's stock worth $6,341,000 after buying an additional 4,740 shares during the period. Pzena Investment Management LLC acquired a new position in Humana during the second quarter worth approximately $1,749,014,000. Swedbank AB lifted its stake in Humana by 6.2% in the fourth quarter. Swedbank AB now owns 111,803 shares of the insurance provider's stock valued at $28,636,000 after buying an additional 6,534 shares during the last quarter. Finally, North Dakota State Investment Board purchased a new stake in Humana in the fourth quarter valued at approximately $1,517,000. 92.38% of the stock is owned by hedge funds and other institutional investors.
Humana Trading Up 0.6%
Shares of HUM stock opened at $388.92 on Wednesday. The business's fifty day moving average price is $383.88 and its 200 day moving average price is $285.00. The firm has a market capitalization of $46.70 billion, a PE ratio of 36.79, a P/E/G ratio of 2.20 and a beta of 0.72. The company has a debt-to-equity ratio of 0.62, a current ratio of 1.74 and a quick ratio of 1.74. Humana Inc. has a 1-year low of $163.11 and a 1-year high of $428.88.
Humana (NYSE:HUM - Get Free Report) last announced its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, beating the consensus estimate of $7.27 by $0.34. The firm had revenue of $40.89 billion during the quarter, compared to analysts' expectations of $40.58 billion. Humana had a net margin of 0.88% and a return on equity of 11.20%. The business's revenue for the quarter was up 26.2% compared to the same quarter last year. During the same quarter last year, the business earned $6.27 earnings per share. As a group, sell-side analysts forecast that Humana Inc. will post 9.12 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently commented on the stock. Guggenheim lifted their target price on shares of Humana from $269.00 to $471.00 and gave the company a "buy" rating in a report on Thursday, July 30th. Evercore upgraded shares of Humana from an "in-line" rating to an "outperform" rating and set a $480.00 price target for the company in a research note on Wednesday, July 29th. Robert W. Baird set a $390.00 price objective on shares of Humana in a research report on Thursday, July 30th. Truist Financial lifted their price objective on shares of Humana from $320.00 to $415.00 and gave the company a "hold" rating in a research note on Tuesday, July 14th. Finally, Lake Street Capital initiated coverage on shares of Humana in a report on Thursday, July 30th. They issued a "buy" rating for the company. Fourteen investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus target price of $403.91.
Get Our Latest Report on Humana
About Humana
(
Free Report)
Humana Inc NYSE: HUM is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana's products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.
In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Humana, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Humana wasn't on the list.
While Humana currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
